Outcomes of Liver Transplant for Hepatic Epithelioid Hemangioendothelioma
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Emily L Larson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplantation Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Hemangioendothelioma, Epithelioid, Liver Neoplasms, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Johns Hopkins Department of Surgery.
Abstract (Originalsprache)
Introduction
Hepatic epithelioid hemangioendothelioma (HEH) is a rare indication of liver transplant with limited evidence.
Methods
Adult recipients undergoing first‐time liver‐only transplant from 2002 to 2021 in the United States were identified using the UNOS/OPTN database. We compared post‐transplant outcomes of recipients receiving liver transplant for HEH versus other diagnoses. Survival was visualized using Kaplan‐Meier curves and compared using log‐rank test and multivariable Cox regression. Propensity score matching for recipient age, sex, and MELD was performed, with baseline characteristics and survival compared between groups.
Results
Of 111 558 liver transplant recipients identified, 121 (0.1%) underwent transplant for HEH. Donors to HEH recipients were more often living donors. Recipients with HEH were younger, more likely to be female, and had lower BMI. Recipients with HEH had higher albumin, lower bilirubin, lower INR, and lower serum creatinine, as well as lower MELD scores and rates of ascites and encephalopathy. Similar post‐transplant survival was observed for recipients with HEH (16.6 [lower 95% CI 14.9] years) and non‐HEH diagnoses (13.8 [95% CI 13.6–13.9] years, log‐rank p = 0.28), even after adjusting for baseline donor and recipient characteristics (aHR 1.28 [95% CI 0.94–1.74], p = 0.12). The propensity score matched cohort also had similar post‐LT survival.
Conclusions
This national study represents the largest known report on liver transplant for HEH. The survival of recipients with HEH was similar to other etiologies, supporting the use of liver transplantation (LT) in advanced HEH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Transplantation Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA.
ORCID-Profile: Emily L Larson, Reed T Jenkins, Alice L Zhou, Jessica M Ruck
Förderung
- Johns Hopkins Department of Surgery
Zitieren
APA
Larson, E. L., Ciftci, Y., Jenkins, R. T., Zhou, A. L., Ruck, J. M., & Philosophe, B. (2025). Outcomes of Liver Transplant for Hepatic Epithelioid Hemangioendothelioma. Clinical Transplantation. https://doi.org/10.1111/ctr.70087
Vancouver
Larson EL, Ciftci Y, Jenkins RT, Zhou AL, Ruck JM, Philosophe B. Outcomes of Liver Transplant for Hepatic Epithelioid Hemangioendothelioma. Clinical Transplantation. 2025. doi:10.1111/ctr.70087
BibTeX
@article{Larson2025,
author = {Larson, Emily L and Ciftci, Yusuf and Jenkins, Reed T and Zhou, Alice L and Ruck, Jessica M and Philosophe, Benjamin},
title = {Outcomes of Liver Transplant for Hepatic Epithelioid Hemangioendothelioma},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70087}
}
EUVIMED